Holen Sie sich die Stockscreener-App
161.38
0.34%
-0.55
Handel nachbörslich:
161.00
-0.38
-0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
IQM Quantum Computers Appoints Former Illumina VP Craig Ciesla as CTO Ahead of Nasdaq Listing Through Merger with RAAQ – Minichart - Minichart
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth in Genomic Innovation with a 4.8% Revenue Surge - DirectorsTalk Interviews
IQM nomme Craig Ciesla, ancien vice-président d’Illumina, au poste de directeur technique ; Inés de Vega devient directrice scientifique - Eagle-Tribune
Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Why Illumina’s NovaSeq X Plus is quietly reshaping high-throughput genomics - AD HOC NEWS
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist - Business Wire
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research - Illumina
Illumina Inc (ILMN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Illumina StockCasdin Capital and Gotham build positions as consensus stays cautious - AD HOC NEWS
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Illumina Inc (ILMN) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Illumina Inc (ILMN) Institutional Confidence - TradingKey
Illumina Inc (ILMN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Illumina Inc (ILMN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Illumina Inc (ILMN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Illumina Inc (ILMN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DRAGEN™ v4.5 | Push-Button Oncology Research Pipelines: FASTQ In, Report Out - Illumina
Illumina Connected Analytics brings clinical-grade genomics to the cloud for hospitals and labs - AD HOC NEWS
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. Stock (US4523271090): Quarterly earnings and strategic reset in focus - AD HOC NEWS
New spatial twist, Illumina StrataMap Spatial Solution targets multi-omics labs - AD HOC NEWS
Is Illumina Inc (ILMN) Overvalued After 3.7% Rally? GF Value Say - GuruFocus
Illumina Inc. Stock (US4523271090): Analyst sentiment leans bullish after strong 12-month rebound - AD HOC NEWS
Illumina, Inc. (ILMN): Investor Outlook On A Genomic Pioneer With A 33.82% ROE - DirectorsTalk Interviews
What is proteomics? A simple guide to understanding measuring proteins at scale - Illumina
Illumina raised to overweight at JP Morgan after customer survey - MSN
Illumina Inc. Stock (US4523271090): shares steady as investors await next earnings catalyst - AD HOC NEWS
Liquidity Mapping Around (ILMN) Price Events - Stock Traders Daily
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Inc (ILMN) Stock Down 3.1% but Still Overvalued -- GF S - GuruFocus
Illumina slides 3.1% as investors digest insider/holder selling signals and a quiet news tape - Quiver Quantitative
When sequencing isn’t enough: A global forum for finding answers - Illumina
Illumina Stock’s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target? - TIKR.com
Fox Run Management L.L.C. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Loomis Sayles Growth Portfolio's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina stock upgraded at J.P. Morgan (ILMN:NASDAQ) - Seeking Alpha
Illumina (NASDAQ:ILMN) Shares Gap Up After Analyst Upgrade - MarketBeat
JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185 - marketscreener.com
Amova Asset Management Americas Inc. Reduces Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina SVP Patricia Leckman sells $127,304 in company stock By Investing.com - Investing.com Australia
Illumina SVP Patricia Leckman sells $127,304 in company stock - Investing.com UK
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
Illumina (ILMN) Chief People Officer sells 783 common shares - Stock Titan
Illumina Inc. stock (US4523271090): new StrataMap launch after strong 12?month rally - AD HOC NEWS
Templeton Global Smaller Companies Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina launches StrataMap Spatial Solution, a powerful end-to- - GuruFocus
8 Cancer organizations receive grants to expand access to genomic testing - Illumina
Illumina Launches StrataMap Spatial Solution for Whole Transcriptome Analysis - geneonline.com
Illumina launches StrataMap Spatial research solution By Investing.com - Investing.com Canada
Illumina launches StrataMap Spatial research solution - Investing.com
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - Illumina
Capital International Inc. CA Boosts Stock Position in Illumina, Inc. $ILMN - MarketBeat
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Capital International Ltd. CA - MarketBeat
Capital World Investors Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Sells 15,683 Shares of Illumina, Inc. $ILMN - MarketBeat
1.68%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):